Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Agius, Rudi, Brieghel, Christian ORCID: 0000-0002-1816-8106, Andersen, Michael A., Pearson, Alexander T., Ledergerber, Bruno, Cozzi-Lepri, Alessandro, Louzoun, Yoram, Andersen, Christen L., Bergstedt, Jacob ORCID: 0000-0002-9279-6936, von Stemann, Jakob H., Jorgensen, Mette, Tang, Man-Hung Eric ORCID: 0000-0002-3483-0219, Fontes, Magnus, Bahlo, Jasmin, Herling, Carmen D., Hallek, Michael, Lundgren, Jens, MacPherson, Cameron Ross, Larsen, Jan ORCID: 0000-0003-1880-1810 and Niemann, Carsten U. (2020). Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nat. Commun., 11 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M., Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Du, Katell, Fogliatto, Laura M., Niemann, Carsten U., Weinkove, Robert, Robinson, Sue, Kipps, Thomas J., Tausch, Eugen, Schary, William, Ritgen, Matthias, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Eichhorst, Barbara, Stilgenbauer, Stephan, Hallek, Michael and Fischer, Kirsten (2020). Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol., 21 (9). S. 1188 - 1201. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Brieghel, Christian ORCID: 0000-0002-1816-8106, Galle, Veerle, Agius, Rudi, Da Cunha-Bang, Caspar, Andersen, Michael A., Vlummens, Philip ORCID: 0000-0001-8275-2887, Mattsson, Mattias ORCID: 0000-0002-9510-8801, Rosenquist, Richard ORCID: 0000-0002-0211-8788, Smedby, Karin E., Herling, Carmen D., Bahlo, Jasmin, Hallek, Michael ORCID: 0000-0002-7425-4455, Lundgren, Jens D., Offner, Fritz and Niemann, Carsten U. (2022). Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? Eur. J. Haematol., 108 (5). S. 369 - 379. HOBOKEN: WILEY. ISSN 1600-0609

Chatzikonstantinou, Thomas, Kapetanakis, Anargyros, Scarfo, Lydia, Karakatsoulis, Georgios, Allsup, David ORCID: 0000-0001-6159-6109, Alonso Cabrero, Alejandro, Andres, Martin ORCID: 0000-0001-9891-2988, Antic, Darko, Baile, Monica, Baliakas, Panagiotis, Bron, Dominique, Capasso, Antonella, Chatzileontiadou, Sofia, Cordoba, Raul, Correa, Juan-Gonzalo, Cuellar-Garcia, Carolina, De Paoli, Lorenzo, De Paolis, Maria Rosaria, Del Poeta, Giovanni, Demosthenous, Christos, Dimou, Maria, Donaldson, David, Doubek, Michael, Efstathopoulou, Maria, Eichhorst, Barbara, El-Ashwah, Shaimaa, Enrico, Alicia, Espinet, Blanca ORCID: 0000-0002-4294-8145, Farina, Lucia, Ferrari, Angela, Foglietta, Myriam, Frederiksen, Henrik ORCID: 0000-0001-8905-0220, Furstenau, Moritz, Garcia-Marco, Jose A., Garcia-Serra, Rocio, Gentile, Massimo, Gimeno, Eva, Glenthoj, Andreas, da Silva, Maria Gomes, Gutwein, Odit, Hakobyan, Yervand K., Herishanu, Yair, Angel Hernandez-Rivas, Jose, Herold, Tobias ORCID: 0000-0002-9615-9432, Innocenti, Idanna, Itchaki, Gilad, Jaksic, Ozren, Janssens, Ann, Kalashnikova, Olga B., Kalicinska, Elzbieta ORCID: 0000-0002-4797-8001, Karlsson, Linda Katharina, Kater, Arnon P., Kersting, Sabina, Labrador, Jorge, Lad, Deepesh ORCID: 0000-0003-3754-7774, Laurenti, Luca, Levin, Mark-David, Lista, Enrico, Lopez-Garcia, Alberto, Malerba, Lara, Marasca, Roberto, Marchetti, Monia, Marquet, Juan, Mattsson, Mattias, Mauro, Francesca R., Milosevic, Ivana, Miras, Fatima, Morawska, Marta ORCID: 0000-0001-6836-2903, Motta, Marina, Munir, Talha, Murru, Roberta, Niemann, Carsten U., Rodrigues, Raquel Nunes, Olivieri, Jacopo, Orsucci, Lorella, Papaioannou, Maria, Arturo Pavlovsky, Miguel, Piskunova, Inga, Popov, Viola Maria, Quaglia, Francesca Maria, Quaresmini, Giulia, Qvist, Kristian, Reda, Gianluigi, Rigolin, Gian Matteo, Ruchlemer, Rosa, Saghumyan, Gevorg, Shrestha, Amit, Simkovic, Martin ORCID: 0000-0003-0331-5334, Spacek, Martin, Sportoletti, Paolo, Stanca, Oana, Stavroyianni, Niki, Tadmor, Tamar, Te Raa, Doreen, Tonino, Sanne H., Trentin, Livio, Van der Spek, Ellen, van Gelder, Michel, van Kampen, Roel, Varettoni, Marzia, Visentin, Andrea ORCID: 0000-0003-0271-7200, Vitale, Candida, Wasik-Szczepanek, Ewa, Wrobel, Tomasz ORCID: 0000-0002-6612-3535, Yanez San Segundo, Lucrecia, Yassin, Mohamed, Coscia, Marta, Rambaldi, Alessandro, Montserrat, Emili, Foa, Robin, Cuneo, Antonio, Stamatopoulos, Kostas and Ghia, Paolo (2021). COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia, 35 (12). S. 3444 - 3455. LONDON: SPRINGERNATURE. ISSN 1476-5551

Fuerstenau, Moritz, Langerbeins, Petra, De Silva, Nisha, Fink, Anna Maria, Robrecht, Sandra, von Tresckow, Julia, Simon, Florian, Hohloch, Karin, Droogendijk, Jolanda, van der Klift, Marjolein, van der Spek, Ellen, Illmer, Thomas, Schoettker, Bjoern, Fischer, Kirsten, Wendtner, Clemens M., Tausch, Eugen, Stilgenbauer, Stephan, Niemann, Carsten U., Gregor, Michael, Kater, Arnon P., Hallek, Michael and Eichhorst, Barbara (2020). COVID-19 among fit patients with CLL treated with venetoclax-based combinations. Leukemia, 34 (8). S. 2225 - 2230. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Huber, Henriette, Edenhofer, Simone, von Tresckow, Julia, Robrecht, Sandra, Zhang, Can, Tausch, Eugen, Schneider, Christof, Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Fuerstenau, Moritz, Dreger, Peter, Ritgen, Matthias, Illmer, Thomas, Illert, Anna L., Duerig, Jan, Boettcher, Sebastian, Niemann, Carsten U., Kneba, Michael, Fink, Anna-Maria, Fischer, Kirsten, Doehner, Hartmut, Hallek, Michael ORCID: 0000-0002-7425-4455, Eichhorst, Barbara and Stilgenbauer, Stephan (2022). Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia. Blood, 139 (9). S. 1318 - 1330. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri Nov 22 19:46:25 2024 CET.